XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Knowing when to sell index funds in a recession helps protect capital and rebalance for future growth. This intro offers timing considerations.
15,106 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
A U.S. equity ETF with about $11 billion in assets is beating the broad market by favoring profitable, attractively v...
Midweek markets staged a notable reversal as Nasdaq-led tech names helped spark a Wednesday comeback. This guide expl...
January data shows the fed's favored inflation gauge staying elevated, underscoring persistent price pressures as pol...
AI-driven cyber threats are accelerating, but the WisdomTree Cybersecurity Fund remains under pressure as its index c...
In a markets backdrop marked by higher rates and sector stresses, SRET continues to pay monthly distributions, unders...
A new nationwide survey finds just 23% of Americans correctly estimate the odds of needing long-term care in retireme...
Huawei announces a new path to 1.4-nanometer chips by 2031, claiming it can close the gap with TSMC without EUV equip...
Health care cost growth continues to outpace Social Security COLAs, sparking protests from retirees and prompting con...
April data show the fed's favored inflation gauge rose modestly, keeping inflation well above the 2% target. Analysts...
Micron and Intel led a tech selloff that pushed the sector into a correction, amplifying volatility as investors reca...
SpaceX’s public-market debut fueled an ascent in Elon Musk’s net worth to about $1.32 trillion, surpassing Bitcoin’s ...